COURT DIAGNOSTIC AND TREATMENT CENTER — United States · Federal contract register · Supplier record: 9 contracts, all years ($55,478 · Oct 2012 – Jul 2026); $39.9K since January 2024 (6 contracts · 1 agency); 286th rank in the line (of 309 suppliers · 0.0%); 4 agencies never served ($288M on the line without COURT DIAGNOSTIC AND TREATMENT CENTER).
Assay record ASY-US-1ED6UPS1VI · Cite as: Assay Systems, “COURT DIAGNOSTIC AND TREATMENT CENTER in the USAspending register”, https://assay-systems.com/register/us/court-diagnostic-and-treatment-center/
9
contracts, all years
$55,478 · Oct 2012 – Jul 2026
$39.9K
since January 2024
6 contracts · 1 agency
286th
rank in the line
of 309 suppliers · 0.0%
4
agencies never served
$288M on the line without COURT DIAGNOSTIC AND TREATMENT CENTER
Own record by year
2023 onward
$7.5K
$17.4K
$14.6K
$8.0K
2023202420252026
Who buys from COURT DIAGNOSTIC AND TREATMENT CENTER
since January 2024
1agencies
$39.9Kpaid
100.0%top buyer
Department of Justice100.0%
$39,921
The line
since January 2024
$1.5Bline value
1,886contracts
5agencies
309suppliers
44.9%held by top ten
Social rehabilitation (G004)
$537M
$672M
$303M
202420252026Jan–Sep
286thof 309 suppliers
$39,921COURT DIAGNOSTIC AND TREATMENT CENTER in the line
0.0%share of the line
0.0%of $1,225,075,306 spent by Department of Justice
Agencies that buy the line and never bought from COURT DIAGNOSTIC AND TREATMENT CENTER
4agencies
443contracts
$287,663,056since January 2024
Department of Veterans Affairs432 contracts
$281,366,869
Court Services and Offender Supervision Agency9 contracts
$5,796,113
Department of Health and Human Services1 contract
$500,000
Department of State1 contract
$74
How the line is bought
by value, since 2024
3%no competition
4%one applicant
0of these to COURT DIAGNOSTIC AND TREATMENT CENTER
Competed, several suppliers applied1,636 contracts
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.